|
Federal
Register Notices > Manufacturers
2009 > Sigma Aldrich
Research Biochemicals, Inc.
FR Doc E9-3646[Federal Register: February 20, 2009 (Volume 74, Number 33)]
[Notices] [Page 7924] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20fe09-92]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR),
this is notice that on January 8, 2009, Sigma Aldrich Research Biochemicals,
Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-2447, made application by
renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of
the basic classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
Aminorex (1585)
|
I
|
|
Gamma Hydroxybutyric Acid (2010)
|
I
|
|
Alpha-ethyltryptamine (7249)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (MDMA) (7405)
|
I
|
|
Psilocybin (7437)
|
I
|
|
5-Methoxy-N,N-diisopropyltryptamine (7439)
|
I
|
|
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) (7470)
|
I
|
|
1-Benzylpiperazine (BZP) (7493)
|
I
|
|
Heroin (9200)
|
I
|
|
Normorphine (9313)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Nabilone (7379)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Diprenorphine (9058)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Levomethorphan (9210)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Metazocine (9240)
|
II
|
|
Methadone (9250)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Carfentanil (9743)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture reference standards. Any other such
applicant, and any person who is presently registered with DEA to manufacture
such substances, may file comments or objections to the issuance of the proposed
registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in quintuplicate,
to the Drug Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia
22152; and must be filed no later than April 21, 2009.
Dated: February 13, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E9-3646 Filed 2-19-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
